Thursday, Oct 22, 2026
Focus on the big picture

Moderna plans stock buyback, sales forecast unchanged

Reuters, 04 Aug 2022
Moderna maintained its full-year COVID vaccine sales forecast of $21 billion as canceled orders from the COVAX program offset gains from new booster dose orders.

#moderna #covid #covax #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles